[1] 赵红, 谢雯. 药物性肝损伤的治疗现状. 中华肝脏病杂志, 2016, 24: 804-806. [2] 刘丽萍, 郑松柏. 药物性肝损伤的流行病学研究现状. 中国新药与临床杂志, 2017: 380-384. [3] 张文勇, 沈秀娟, 徐闻涛,等. 非活动性 HBsAg 携带患者服生何首乌致亚急性肝衰竭1例. 肝脏, 2015: 425-426. [4] Björnsson ES, Bergmann OM, Björnsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology, 2013, 144: 1419-1425. [5] Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol, 2014, 109: 950-966. [6] 丁辉, 王琳琳, 余河水,等. 何首乌炮制研究进展. 辽宁中医药大学学报, 2015: 212-215. [7] Kullak-Ublick GA, Andrade RJ, Merz M, et al. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut, 2017, 66: 1154-1164. [8] 杨敏, 刘婷, 冯伟红,等. 何首乌肝毒性物质基础探索研究. 中国中药杂志, 2016, 41: 1289-1296. [9] 党和勤, 王彦辉, 李长秀,等. 番泻叶致急性肝肾功能损害1例. 中国临床药学杂志, 2017: 142-142. [10] George N, Chen M, Yuen N, et al. Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. Regul Toxicol Pharm, 2018, 94: 101-107. [11] 中华中医药学会肝胆病分会,中华中医药学会中成药分会. 中草药相关肝损伤临床诊疗指南. 临床肝胆病杂志, 2016, 41: 1165-1172. [12] 陈成伟. 认真回顾研究重视RUCAM量表在药物性肝损伤诊断中的应用. 中华肝脏病杂志, 2016, 24: 801-803. |